Research ExplorerPublications2022 EULAR points to consider for remote care in rheumatic a...

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

Standard

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. / de Thurah, Annette; Bosch, Philipp; Marques, Andrea; Meissner, Yvette; Mukhtyar, Chetan B; Knitza, Johannes; Najm, Aurélie; Østerås, Nina; Pelle, Tim; Knudsen, Line Raunsbæk; Šmucrová, Hana; Berenbaum, Francis; Jani, Meghna; Geenen, Rinie; Krusche, Martin; Pchelnikova, Polina; de Souza, Savia; Badreh, Sara; Wiek, Dieter; Piantoni, Silvia; Gwinnutt, James M; Duftner, Christina; Canhão, Helena M; Quartuccio, Luca; Stoilov, Nikolay; Prior, Yeliz; Bijlsma, Johannes Wj; Zabotti, Alen; Stamm, Tanja A; Dejaco, Christian.

In: ANN RHEUM DIS, Vol. 81, No. 8, 08.2022, p. 1065-1071.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

de Thurah, A, Bosch, P, Marques, A, Meissner, Y, Mukhtyar, CB, Knitza, J, Najm, A, Østerås, N, Pelle, T, Knudsen, LR, Šmucrová, H, Berenbaum, F, Jani, M, Geenen, R, Krusche, M, Pchelnikova, P, de Souza, S, Badreh, S, Wiek, D, Piantoni, S, Gwinnutt, JM, Duftner, C, Canhão, HM, Quartuccio, L, Stoilov, N, Prior, Y, Bijlsma, JW, Zabotti, A, Stamm, TA & Dejaco, C 2022, '2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases', ANN RHEUM DIS, vol. 81, no. 8, pp. 1065-1071. https://doi.org/10.1136/annrheumdis-2022-222341

APA

de Thurah, A., Bosch, P., Marques, A., Meissner, Y., Mukhtyar, C. B., Knitza, J., Najm, A., Østerås, N., Pelle, T., Knudsen, L. R., Šmucrová, H., Berenbaum, F., Jani, M., Geenen, R., Krusche, M., Pchelnikova, P., de Souza, S., Badreh, S., Wiek, D., ... Dejaco, C. (2022). 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. ANN RHEUM DIS, 81(8), 1065-1071. https://doi.org/10.1136/annrheumdis-2022-222341

Vancouver

de Thurah A, Bosch P, Marques A, Meissner Y, Mukhtyar CB, Knitza J et al. 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. ANN RHEUM DIS. 2022 Aug;81(8):1065-1071. https://doi.org/10.1136/annrheumdis-2022-222341

Bibtex

@article{682af3ad21284833b8bcc997af6b0eb7,
title = "2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases",
abstract = "BACKGROUND: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD).OBJECTIVE: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD.METHODS: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting.RESULTS: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible.The level of agreement to each statement ranged from 8.5 to 9.8/10.CONCLUSION: The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.",
keywords = "COVID-19, Health Services Accessibility, Humans, Musculoskeletal Diseases/therapy, Pandemics, Telemedicine",
author = "{de Thurah}, Annette and Philipp Bosch and Andrea Marques and Yvette Meissner and Mukhtyar, {Chetan B} and Johannes Knitza and Aur{\'e}lie Najm and Nina {\O}ster{\aa}s and Tim Pelle and Knudsen, {Line Raunsb{\ae}k} and Hana {\v S}mucrov{\'a} and Francis Berenbaum and Meghna Jani and Rinie Geenen and Martin Krusche and Polina Pchelnikova and {de Souza}, Savia and Sara Badreh and Dieter Wiek and Silvia Piantoni and Gwinnutt, {James M} and Christina Duftner and Canh{\~a}o, {Helena M} and Luca Quartuccio and Nikolay Stoilov and Yeliz Prior and Bijlsma, {Johannes Wj} and Alen Zabotti and Stamm, {Tanja A} and Christian Dejaco",
note = "{\textcopyright} Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2022",
month = aug,
doi = "10.1136/annrheumdis-2022-222341",
language = "English",
volume = "81",
pages = "1065--1071",
journal = "ANN RHEUM DIS",
issn = "0003-4967",
publisher = "BMJ PUBLISHING GROUP",
number = "8",

}

RIS

TY - JOUR

T1 - 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

AU - de Thurah, Annette

AU - Bosch, Philipp

AU - Marques, Andrea

AU - Meissner, Yvette

AU - Mukhtyar, Chetan B

AU - Knitza, Johannes

AU - Najm, Aurélie

AU - Østerås, Nina

AU - Pelle, Tim

AU - Knudsen, Line Raunsbæk

AU - Šmucrová, Hana

AU - Berenbaum, Francis

AU - Jani, Meghna

AU - Geenen, Rinie

AU - Krusche, Martin

AU - Pchelnikova, Polina

AU - de Souza, Savia

AU - Badreh, Sara

AU - Wiek, Dieter

AU - Piantoni, Silvia

AU - Gwinnutt, James M

AU - Duftner, Christina

AU - Canhão, Helena M

AU - Quartuccio, Luca

AU - Stoilov, Nikolay

AU - Prior, Yeliz

AU - Bijlsma, Johannes Wj

AU - Zabotti, Alen

AU - Stamm, Tanja A

AU - Dejaco, Christian

N1 - © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2022/8

Y1 - 2022/8

N2 - BACKGROUND: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD).OBJECTIVE: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD.METHODS: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting.RESULTS: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible.The level of agreement to each statement ranged from 8.5 to 9.8/10.CONCLUSION: The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.

AB - BACKGROUND: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD).OBJECTIVE: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD.METHODS: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting.RESULTS: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible.The level of agreement to each statement ranged from 8.5 to 9.8/10.CONCLUSION: The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.

KW - COVID-19

KW - Health Services Accessibility

KW - Humans

KW - Musculoskeletal Diseases/therapy

KW - Pandemics

KW - Telemedicine

U2 - 10.1136/annrheumdis-2022-222341

DO - 10.1136/annrheumdis-2022-222341

M3 - SCORING: Journal article

C2 - 35470160

VL - 81

SP - 1065

EP - 1071

JO - ANN RHEUM DIS

JF - ANN RHEUM DIS

SN - 0003-4967

IS - 8

ER -